RBA vs UTHR · P/E 53, rev $2.55B vs P/E 20, rev $1.56B
RB Global Inc. (RBA) versus United Therapeutics Corporation (UTHR) — a side-by-side from cached financials, not a winner call.
RB Global Inc. (RBA) is a specialty business services company listed on US.
United Therapeutics Corporation (UTHR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported RBA revenue for 2026-06-30 was $2.55B. Net income was $279.0M. RBA currently screens at market cap $20.03B and trailing P/E 53.0.
Latest reported UTHR revenue for 2026-06-30 was $1.56B. Net income was $607.9M. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
RBA currently screens at market cap $20.03B and trailing P/E 53.0. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
Not investment advice. Open the RBA and UTHR stock pages for the full models.
Not investment advice.